381 related articles for article (PubMed ID: 16814407)
1. Interaction of atrial natriuretic peptide, urodilatin, guanylin and uroguanylin in the isolated perfused rat kidney.
Santos-Neto MS; Carvalho AF; Monteiro HS; Forte LR; Fonteles MC
Regul Pept; 2006 Sep; 136(1-3):14-22. PubMed ID: 16814407
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the actions of atrial natriuretic peptide (ANP), guanylin and uroguanylin on the isolated kidney.
Santos-Neto MS; Carvalho AF; Forte LR; Fonteles MC
Braz J Med Biol Res; 1999 Aug; 32(8):1015-9. PubMed ID: 10454764
[TBL] [Abstract][Full Text] [Related]
3. Renal effects of uroguanylin and guanylin in vivo.
Carrithers SL; Hill MJ; Johnson BR; O'Hara SM; Jackson BA; Ott CE; Lorenz J; Mann EA; Giannella RA; Forte LR; Greenberg RN
Braz J Med Biol Res; 1999 Nov; 32(11):1337-44. PubMed ID: 10559834
[TBL] [Abstract][Full Text] [Related]
4. Guanylin peptide family: history, interactions with ANP, and new pharmacological perspectives.
Fonteles MC; do Nascimento NR
Can J Physiol Pharmacol; 2011 Aug; 89(8):575-85. PubMed ID: 21815750
[TBL] [Abstract][Full Text] [Related]
5. Structure and activity of OK-GC: a kidney receptor guanylate cyclase activated by guanylin peptides.
London RM; Eber SL; Visweswariah SS; Krause WJ; Forte LR
Am J Physiol; 1999 Jun; 276(6):F882-91. PubMed ID: 10362777
[TBL] [Abstract][Full Text] [Related]
6. Natriuretic and kaliuretic activities of guanylin and uroguanylin in the isolated perfused rat kidney.
Fonteles MC; Greenberg RN; Monteiro HS; Currie MG; Forte LR
Am J Physiol; 1998 Aug; 275(2):F191-7. PubMed ID: 9691007
[TBL] [Abstract][Full Text] [Related]
7. Guanylin peptides: cyclic GMP signaling mechanisms.
Forte LR; Freeman RH; Krause WJ; London RM
Braz J Med Biol Res; 1999 Nov; 32(11):1329-36. PubMed ID: 10559833
[TBL] [Abstract][Full Text] [Related]
8. High salt intake increases uroguanylin expression in mouse kidney.
Potthast R; Ehler E; Scheving LA; Sindic A; Schlatter E; Kuhn M
Endocrinology; 2001 Jul; 142(7):3087-97. PubMed ID: 11416031
[TBL] [Abstract][Full Text] [Related]
9. The proximal convoluted tubule is a target for the uroguanylin-regulated natriuretic response.
Elitsur N; Lorenz JN; Hawkins JA; Rudolph JA; Witte D; Yang LE; McDonough AA; Cohen MB
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S74-81. PubMed ID: 16819406
[TBL] [Abstract][Full Text] [Related]
10. Guanylin, uroguanylin, and heat-stable euterotoxin activate guanylate cyclase C and/or a pertussis toxin-sensitive G protein in human proximal tubule cells.
Sindiće A; Başoglu C; Cerçi A; Hirsch JR; Potthast R; Kuhn M; Ghanekar Y; Visweswariah SS; Schlatter E
J Biol Chem; 2002 May; 277(20):17758-64. PubMed ID: 11889121
[TBL] [Abstract][Full Text] [Related]
11. Uroguanylin: structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase.
Hamra FK; Forte LR; Eber SL; Pidhorodeckyj NV; Krause WJ; Freeman RH; Chin DT; Tompkins JA; Fok KF; Smith CE
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10464-8. PubMed ID: 7902563
[TBL] [Abstract][Full Text] [Related]
12. Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor.
Carrithers SL; Ott CE; Hill MJ; Johnson BR; Cai W; Chang JJ; Shah RG; Sun C; Mann EA; Fonteles MC; Forte LR; Jackson BA; Giannella RA; Greenberg RN
Kidney Int; 2004 Jan; 65(1):40-53. PubMed ID: 14675035
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of guanylin action via cyclic GMP in the kidney.
Forte LR; London RM; Krause WJ; Freeman RH
Annu Rev Physiol; 2000; 62():673-95. PubMed ID: 10845107
[TBL] [Abstract][Full Text] [Related]
14. Uroguanylin inhibits proliferation of pancreatic cancer cells.
Kloeters O; Friess H; Giese N; Buechler MW; Cetin Y; Kulaksiz H
Scand J Gastroenterol; 2008; 43(4):447-55. PubMed ID: 18365910
[TBL] [Abstract][Full Text] [Related]
15. Comparison of effects of uroguanylin, guanylin, and Escherichia coli heat-stable enterotoxin STa in mouse intestine and kidney: evidence that uroguanylin is an intestinal natriuretic hormone.
Greenberg RN; Hill M; Crytzer J; Krause WJ; Eber SL; Hamra FK; Forte LR
J Investig Med; 1997 Jun; 45(5):276-82. PubMed ID: 9250001
[TBL] [Abstract][Full Text] [Related]
16. Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics.
Forte LR
Pharmacol Ther; 2004 Nov; 104(2):137-62. PubMed ID: 15518884
[TBL] [Abstract][Full Text] [Related]
17. Guanylin peptides: renal actions mediated by cyclic GMP.
Forte LR; London RM; Freeman RH; Krause WJ
Am J Physiol Renal Physiol; 2000 Feb; 278(2):F180-91. PubMed ID: 10662722
[TBL] [Abstract][Full Text] [Related]
18. Guanylin regulatory peptides: structures, biological activities mediated by cyclic GMP and pathobiology.
Forte LR
Regul Pept; 1999 May; 81(1-3):25-39. PubMed ID: 10395405
[TBL] [Abstract][Full Text] [Related]
19. Uroguanylin and guanylin regulate transport of mouse cortical collecting duct independent of guanylate cyclase C.
Sindić A; Velic A; Başoglu C; Hirsch JR; Edemir B; Kuhn M; Schlatter E
Kidney Int; 2005 Sep; 68(3):1008-17. PubMed ID: 16105031
[TBL] [Abstract][Full Text] [Related]
20. Cellular effects of guanylin and uroguanylin.
Sindić A; Schlatter E
J Am Soc Nephrol; 2006 Mar; 17(3):607-16. PubMed ID: 16382016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
